|
|
|
|
|
| |
 |
ActivBiotics
Canada Inc.
ActivBiotics is a late clinical-stage biotechnology
company that discovers, develops and commercializes
therapies for the treatment of inflammatory diseases
and bacterial infections. |
|
|
|
 |
Adherex
Technologies Inc.
Adherex is a clinical-stage company dedicated
to developing new therapies for cancer
and cancer side effects. |
|
|
| |
 |
Aegera
Oncology Inc.
Aegera is a clinical-stage biotechnology company that develops
drugs to treat cancer and other serious
diseases including pain
related to diabetes and other injuries. |
|
|
|
 |
Axela
Biosensors Inc.
Axela develops
technologies for protein detection,
characterization and monitoring for
use in life science, health and clinical
research. |
|
|
| |
 |
Cytochroma Canada
Inc.
Cytochroma is a clinical-stage biotechnology
firm, which develops proprietary products
to treat and prevent the clinical consequences
of vitamin D deficiency, with a specific
focus on chronic kidney disease and related
complications. |
|
|
|
 |
Interface
Biologics Inc.
Interface develops unique biomaterials
for the coating and manufacturing of
a new generation of medical devices to
improve compatibility, efficacy and safety. |
|
|
| |
 |
Targanta
Therapeutics (Ontario) Inc.
Targanta Therapeutics, Inc. is a late clinical-stage biopharmaceutical company focused on developing
and commercializing novel antibacterial agents
to address life-threatening infections
for the hospital market. |
|
|
| |
 |
Trillium
Therapeutics Inc.
Trillium develops
therapies that restore balance to the
immune system for many conditions such
as autoimmune and inflammatory disorders
as well as cancer. |
|
|
|
 |
VisualSonics
Inc.
VisualSonics is
the world’s leading developer
of high-resolution, ultrasound based in-vivo
micro-imaging systems, specifically designed
for non-invasive pre-clinical research. |
|
|
|
 |
Xceed
Molecular Inc.
Xceed is a molecular diagnostics company, providing scientists and clinical researchers with innovative systems to translate novel multiplex gene expression tests into routine clinical practice. |
|
|
| |
 |
Zelos
Therapeutics Inc.
Zelos is a biopharmaceutical
company developing novel therapies for
patients suffering from conditions responsive
to parathyroid hormone-based therapeutics.
The Company is in late-stage clinical development
with Ostabolin-C™, a parathyroid
hormone analogue designed to improve upon
the safety and efficacy of current therapies
in the large and rapidly growing osteoporosis
market. |
|
|
|
 |
Z-Tech
(Canada) Inc.
Committed to improving breast cancer survivor
rates, Z-Tech develops and markets revolutionary
radiation-free breast screening products. |
| |
|
|
.gif){kind=small}
